Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons with Multiple Sclerosis in Sweden

Kyla A. McKay; Fredrik Piehl; Simon Englund; Anna He; Annette Langer-Gould; Jan Hillert; Thomas Frisell

doi:10.1001/jamanetworkopen.2021.36697

Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons with Multiple Sclerosis in Sweden

Kyla A. McKay
, Fredrik Piehl
, Simon Englund
, Anna He
, Annette Langer-Gould
, Jan Hillert
, Thomas Frisell

Research output: Contribution to journal › Letter › Research › peer-review

Original language	English
Article number	e2136697
Number of pages	4
Journal	JAMA Network Open
Volume	4
Issue number	12
DOIs	https://doi.org/10.1001/jamanetworkopen.2021.36697
Publication status	Published - 2 Dec 2021
Externally published	Yes

Access to Document

10.1001/jamanetworkopen.2021.36697Licence: CC BY

Cite this

@article{9460483543bf41dda687cfbdc818cfae,

title = "Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons with Multiple Sclerosis in Sweden",

author = "McKay, \{Kyla A.\} and Fredrik Piehl and Simon Englund and Anna He and Annette Langer-Gould and Jan Hillert and Thomas Frisell",

year = "2021",

month = dec,

day = "2",

doi = "10.1001/jamanetworkopen.2021.36697",

language = "English",

volume = "4",

journal = "JAMA Network Open",

issn = "2574-3805",

publisher = "American Medical Association (AMA)",

number = "12",

}

TY - JOUR

T1 - Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons with Multiple Sclerosis in Sweden

AU - McKay, Kyla A.

AU - Piehl, Fredrik

AU - Englund, Simon

AU - He, Anna

AU - Langer-Gould, Annette

AU - Hillert, Jan

AU - Frisell, Thomas

PY - 2021/12/2

Y1 - 2021/12/2

UR - https://www.scopus.com/pages/publications/85120969629

U2 - 10.1001/jamanetworkopen.2021.36697

DO - 10.1001/jamanetworkopen.2021.36697

M3 - Letter

C2 - 34851401

AN - SCOPUS:85120969629

SN - 2574-3805

VL - 4

JO - JAMA Network Open

JF - JAMA Network Open

IS - 12

M1 - e2136697

ER -

Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons with Multiple Sclerosis in Sweden

Access to Document

Other files and links

Cite this